Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 385 entries
View as:

Mycophenolate Mofetil in Gastrointestinal Henoch-Schonlein Purpura

Phase: N/A Priority: Normal
NCT ID: NCT05951517 Org: User:
Start: 01/01/23 End: 12/31/26 Due: 12/31/27

Pre-warning Risk Scoring System for Sudden Cardiac Death

Phase: N/A Priority: Normal
NCT ID: NCT06440083 Org: User:
Start: 03/02/23 End: 12/31/27 Due: 12/31/28

Neoadjuvant Tirellizumab Combined With Chemotherapy for Early Oral Squamous Cell Carcinoma(HNC-SYSU-004)

Phase: N/A Priority: Normal
NCT ID: NCT06130332 Org: User:
Start: 09/01/23 End: 08/31/30 Due: 08/31/31

Efficacy and Safety of SHR-A1811 Followed by Dalpiciclib and Endocrine Therapy in HR+/HER2-Low/Ultra-Low Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT07037199 Org: User:
Start: 06/20/25 End: 06/30/30 Due: 06/30/31

Safety and Efficacy of Intrathecal Rituximab in 16 Children of Stage Ⅲ、ⅣNon-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06190457 Org: User:
Start: 09/30/15 End: 08/30/22 Due: 08/30/23

Technological Development and Clinical Parallel Testing of PGT-G

Phase: N/A Priority: Normal
NCT ID: NCT05609708 Org: User:
Start: 12/12/22 End: 11/01/25 Due: 11/01/26

Efficacy, Metabolism and BMD of the 3-month TP Compared to the 1-month TP in ICPP

Phase: N/A Priority: Normal
NCT ID: NCT06487143 Org: User:
Start: 07/01/24 End: 12/30/26 Due: 12/30/27

A Study of Sacituzumab Govitecan Plus Toripalimab Versus Toripalimab Plus Nab-Paclitaxel in PD-L1 Positive Advanced TNBC

Phase: N/A Priority: Normal
NCT ID: NCT07040644 Org: User:
Start: 06/30/25 End: 06/30/28 Due: 06/30/29

A Single-arm Phase II Clinical Study of the Efficacy and Safety of Camrelizumab Combined With GEMOX for Unresectable GBCs

Phase: N/A Priority: Normal
NCT ID: NCT06423170 Org: User:
Start: 06/01/23 End: 12/31/26 Due: 12/31/27

AI-Assisted System for Accurate Diagnosis and Prognosis of Breast Phyllodes Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06286267 Org: User:
Start: 03/01/23 End: 12/31/27 Due: 12/31/28

Disitamab Vedotin (RC48) in Combination With AK104 (PD-1/CTLA-4 Bispecific) and Bevacizumab for the Treatment of Recurrent and Persistent Clear Cell Ovarian Cancer: a Single-arm, Phase II, Multicenter Study (DAB OCC Study)

Phase: N/A Priority: Normal
NCT ID: NCT06540729 Org: User:
Start: 07/31/24 End: 08/01/30 Due: 08/01/31

Endoscopic Breast Conserving Surgery With Intra-operative Navigation System

Phase: N/A Priority: Normal
NCT ID: NCT05458414 Org: User:
Start: 01/01/22 End: 12/31/24 Due: 12/31/25

Deep Learning-Based Analysis of Colorectal Cancer Pathology Images: An Innovative Approach for Predicting Colorectal Cancer Subtypes

Phase: N/A Priority: Normal
NCT ID: NCT06936098 Org: User:
Start: 05/22/23 End: 03/06/24 Due: 03/06/25

Leflunomide for Idiopathic Pulmonary Hemosiderosis in Children

Phase: N/A Priority: Normal
NCT ID: NCT05937191 Org: User:
Start: 06/01/23 End: 12/31/26 Due: 12/31/27

RARC vs LRC in A Multicenter Cohort Study

Phase: N/A Priority: Normal
NCT ID: NCT05885204 Org: User:
Start: 06/01/23 End: 12/31/23 Due: 12/31/24

Ultrasound-Guided Curved Needle Thread Carpal Tunnel Release: Efficacy and Safety of a Single-Center, Single-Arm Clinical Trial

Phase: N/A Priority: Normal
NCT ID: NCT06440070 Org: User:
Start: 01/01/24 End: 12/31/26 Due: 12/31/27

Effect of Bevacizumab on Radiation-induced Brain Necrosis in Patients With Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01621880 Org: User:
Start: 06/30/12 End: 12/31/15 Due: 12/31/16

Infusional FOLFOX Plus Camrelizumab and Apatinib vs HAIC-FOLFOX Plus Camrelizumab and Apatinib for Advanced HCC

Phase: N/A Priority: Normal
NCT ID: NCT06172205 Org: User:
Start: 07/01/23 End: 07/31/27 Due: 07/31/28

Construction and Effect Evaluation of Malignant Fungating Wounds Care Regimen for Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT05457309 Org: User:
Start: 06/24/22 End: 07/30/24 Due: 07/30/25

Efficacy and Safety of Transcutaneous Auricular Vagus Nerve Stimulation on Radiotherapy-Related Neuropathic Pain

Phase: N/A Priority: Normal
NCT ID: NCT05543239 Org: User:
Start: 09/16/22 End: 03/01/24 Due: 03/01/25

Satisfactory Debulking Prediction Model for Advanced Ovarian Cancer Based on PET-CT Image Data

Phase: N/A Priority: Normal
NCT ID: NCT06533709 Org: User:
Start: 06/01/24 End: 05/31/26 Due: 05/31/27

Randomized, Open, Controlled, Multicenter Phase III Clinical Study of Fluzoparib in Combination With Apatinib Versus Investigator-Selected Chemotherapy for HRD-Positive/HER2-negative Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06255392 Org: User:
Start: 02/29/24 End: 03/31/31 Due: 03/31/32

Adebrelimab and a TKI in Combination With GEMOX in First-line Treatment of Advanced Biliary Tract Cancers (BTC)

Phase: N/A Priority: Normal
NCT ID: NCT06320301 Org: User:
Start: 04/01/24 End: 06/01/26 Due: 06/01/27

Rasburicase Treatment in Chronic Gouty Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT05312268 Org: User:
Start: 06/15/22 End: 04/15/25 Due: 04/15/26

First-line Olaparib Combined With Bevacizumab Maintenance Therapy

Phase: N/A Priority: Normal
NCT ID: NCT05440578 Org: User:
Start: 06/30/22 End: 12/31/22 Due: 12/31/23